- ASCO •
- 30 May, 2025 •
- •
Transfusion-related cost and time burden offsets in patients with myelofibrosis treated with pacritinib compared to best available therapy based on PERSIST-2 trial
Abiola Oladapo, Karisse Roman-Torres, Aaron Gerds, Stephen Oh
Michael Marrone, Robert Geller, Abiola Oladapo, Purvi Suthar, Anupama Vasudevan, Michael Vredenburg , Jia Zeng, Raajit Rampal, John Mascarehnas